About Equiscript
Equiscript is a company based in North Charleston (United States) founded in 2009. Equiscript has raised $2.1 million across 2 funding rounds. Equiscript offers products and services including EQ Connect Referral, EQ Medication Adherence, EQ Connect Clinical, EQ Specialty Claims Processing, and EQ Retail Claims Processing. Equiscript operates in a competitive market with competitors including Wellpartner, Pharmaceutical Strategies Group, PharMedQuest, doc&i and 340BDirect, among others.
- Headquarter North Charleston, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.1 M (USD)
in 2 rounds
-
Latest Funding Round
$1 M (USD), Seed
Dec 12, 2023
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Equiscript
Equiscript offers a comprehensive portfolio of products and services, including EQ Connect Referral, EQ Medication Adherence, EQ Connect Clinical, EQ Specialty Claims Processing, and EQ Retail Claims Processing.
Automates referral processes to boost claim capture and savings.
Delivers patient medication history to address adherence risks.
Provides insights into patient clinical history for gap closure.
Manages specialty drug claims to maximize 340B savings.
Streamlines retail pharmacy claims for efficient program management.
People of Equiscript
Unlock access to complete
Funding Insights of Equiscript
Equiscript has successfully raised a total of $2.1M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1 million completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Equiscript
Investment portfolio details for Equiscript
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Equiscript
Detailed financials for Equiscript
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Equiscript Comparisons
Peer comparison for Equiscript
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Equiscript
Equiscript operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Wellpartner, Pharmaceutical Strategies Group, PharMedQuest, doc&i and 340BDirect, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
340B contract pharmacy programs and management services are provided.
|
|
| Locked | Locked | Locked |
Pharmacy intelligence platform and clinical consulting services are provided.
|
|
| Locked | Locked | Locked |
Medical benefit management for specialty healthcare is developed.
|
|
| Locked | Locked | Locked |
Cloud-based prescription transparency software
|
|
| Locked | Locked | Locked |
Delivers tools for managing 340B programs in pharmacies.
|
Detailed competitors of Equiscript
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Equiscript
Complete news archive for Equiscript
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Equiscript
Equiscript was founded in 2009 and raised its 1st funding round 13 years after it was founded.
Equiscript is headquartered in North Charleston, United States. It is registered at North Charleston, South Carolina, United States.
Michael Burkhold is the current CEO of Equiscript.
Equiscript is a funded company, having raised a total of $2.1M across 2 funding rounds to date.
Equiscript was founded in 2009 and is based in North Charleston, United States. Pharmacy management services are offered in the healthcare sector, with a focus on assisting clients in expanding their operations. Patients not utilizing client pharmacies are identified and recruited for home delivery options. Home delivery pharmacy programs are designed and implemented to facilitate these services.
Equiscript's top competitors include Pharmaceutical Strategies Group, Wellpartner and PharMedQuest.
Equiscript offers EQ Connect Referral, EQ Medication Adherence, EQ Connect Clinical, EQ Specialty Claims Processing, and EQ Retail Claims Processing.